Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 901–1,000 of 1,012
Tumor Necrosis factor- and Expression of the Multidrug Resistance-Associated Genes LRP and MRP
Stein, U., Walther, W., Laurençot, C. M., Shoemaker, R. H., Scheffer, G. L., & Scheper, R. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.807 · Cited by 68
Targeting Sphingolipid Metabolism as a Therapeutic Strategy in Cancer Treatment
Janneh, A. H., & Öğretmen, B. (2022) · Cancers · doi:10.3390/cancers14092183 · Cited by 71
Stefan, K., Stefan, S. M., & Wiese, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00788 · Cited by 67
Regulation of Transporters by Nuclear Hormone Receptors: Implications during Inflammation
Teng, S., & Piquette‐Miller, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700102q · Cited by 81
Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1)
Norman, B. H., Gruber, J. M., Hollinshead, S. P., Wilson, J. W., Starling, J. J., Law, K. L., Self, T. D., Tabas, L. B., Williams, D. C., Paul, D. C., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00051-3 · Cited by 67
Pilarski, L. M., Paine, D., McElhaney, J. E., Cass, C. E., & Belch, A. R. (1995) · American Journal of Hematology · doi:10.1002/ajh.2830490411 · Cited by 67
Gutmann, H., Török, M., Fricker, G., Huwyler, J., Beglinger, C., & Drewe, J. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15245-2 · Cited by 77
“Discussion MRP, a member of the ATP-binding cassette transporter superfamily, is a transport protein involved in multidrug resistance (Cole et al., 1992).”
Schultz, M. J., Wijnholds, J., Peppelenbosch, M. P., Vervoordeldonk, M. J., Speelman, P., van Deventer, S. J. H., Borst, P., & van der Poll, T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4059 · Cited by 67
Michieli, M., Damiani, D., Ermacora, A., Raspadori, D., Michelutti, A., Grimaz, S., Fanin, R., RUSSO, D., Lauria, F., Masolini, P., et al. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.d01-2020.x · Cited by 67
“In normal human tissues mrp mRNA is expressed at detectable levels in lung, testis and peripheral blood mononuclear cells, but it is not easily detectable in placenta, brain, kidney, liver or spleen (Cole et al, 1992).”
BackgroundMolecular analysis and heavy metal detoxification of ABCC1/MRP1 in zebrafish
Long, Y., Li, Q., & Cui, Z. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0283-z · Cited by 72
“ABCC1/MRP1 was originally found in a multidrug-resistant human small cell lung cancer cell line [8] and is able to transport a wide range of natural product drugs as well as structurally diverse conjugated and unconjugated organic anions [9, 10].”
BackgroundCurrent options in treatment of anthracycline-resistant breast cancer
Kröger, N. M., Achterrath, W., Hegewisch-Becker, S., Mross, K. B., & Zander, A. R. (1999) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0137 · Cited by 66
Zhou, Y., Li, W., Chen, L., Ma, S., Li, P., & Zhong-lin, Y. (2010) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2010.01.004 · Cited by 66
“The regional difference in the absorption of akebia saponin D between the small and large intestine may be due to the physiological difference in pH of intestinal tract, thickness of mucous layers, tightness and number of the tight junctions and membrane components (Gao et al., 2008).”
BackgroundSteroid/thyroid hormone receptor genes in Caenorhabditis elegans.
Kostrouch, Z., Kostrouchová, M., & Rall, J. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.1.156 · Cited by 66
Rahmanto, Y. S., Kalinowski, D. S., Lane, D. J. R., Lok, H. C., Richardson, V., & Richardson, D. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.329847 · Cited by 68
“MRP1 is a member of the ATP-binding cassette transporter superfamily (71, 72).”
BackgroundSingle-photon agents for tumor imaging:201TI,99mTc-MIBI, and99mTc-tetrofosmin
Fukumoto, M. (2004) · Annals of Nuclear Medicine · doi:10.1007/bf02985098 · Cited by 66
Zhang, D., Cole, S. P. C., & Deeley, R. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105063200 · Cited by 66
Self-citationReversal of anticancer multidrug resistance by the ardeemins
Chou, T., Depew, K. M., Zheng, Y., Safer, M. L., Chan, D. C. F., Helfrich, B. A., Zatorska, D., Zatorski, A., Bornmann, W. G., & Danishefsky, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8369 · Cited by 66
Overview of the pharmacogenetics of HIV therapy
Rodríguez‐Nóvoa, S., Barreiro, P., Jiménez‐Nácher, I., & Soriano, V. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500374 · Cited by 81
Meijer, D. K. F., Smit, J. W., & Müller, M. M. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00498-5 · Cited by 71
Wang, J. M., Chertov, O., Proost, P., Li, J. J., Menton, P., Xu, L., Sozzani, S., Mantovani, A., Gong, W., Schirrmacher, V., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980316)75:6<925::aid-ijc16>3.0.co;2-1 · Cited by 56
Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancer.
Campling, B. G., Young, L. C., Baer, K. A., Lam, Y. M., Deeley, R. G., Cole, S. P. C., & Gerlach, J. H. (1997) · PubMed · Cited by 66
Self-citationGuan, L., Ehrmann, M., Hiroshi Yoneyama, C., & Nakae, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10517 · Cited by 66
Hooiveld, G. J. E. J., van Montfoort, J. E., Meijer, D. K. F., & Müller, M. M. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00186-x · Cited by 66
Damia, G., Imperatori, L., Stefanini, M., & D'Incalci, M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960611)66:6<779::aid-ijc12>3.0.co;2-z · Cited by 132
Defying Multidrug Resistance! Modulation of Related Transporters by Flavonoids and Flavonolignans
Chambers, C. S., Viktorová, J., Řehořová, K., Biedermann, D., Turková, L., Macek, T., Křen, V., & Valentová, K. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b00694 · Cited by 72
Importance of ABCC1 for cancer therapy and prognosis
Kunická, T., & Souček, P. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.901348 · Cited by 79
“Its gene was discovered during the analysis of drug-resistant human small cell lung carcinoma H69AR cell line (Cole et al., 1992).”
BackgroundVadlapudi, A. D., Vadlapatla, R. K., Pal, D., & Mitra, A. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.047 · Cited by 65
Li, J. J., Cao, Y., Young, M. R., & Colburn, N. H. (2000) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200011)29:3<159::aid-mc5>3.0.co;2-w · Cited by 79
Nakagawa, M., Emoto, A., Nasu, N., Hanada, T., Kuwano, M., Cole, S. P. C., & Nomura, Y. (1997) · PubMed · Cited by 65
Self-citationTransport of Fluorescein in MDCKII-MRP1 Transfected Cells and mrp1-Knockout Mice
Sun, H., Johnson, D. R., Finch, R. A., Sartorelli, A. C., Miller, D. W., & Elmquist, W. F. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5062 · Cited by 65
Shirahama, T., Sweeney, E. A., Sakakura, C., Singhal, A. K., Nishiyama, K., Akiyama, S.-I., Hakomori, S., & Igarashi, Y. (1997) · PubMed · Cited by 65
Multidrug resistance protein in recurrent breast cancer
Nooter, K., de la Rivière, G. B., Klijn, J. G. M., Stoter, G., & Foekens, J. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63876-7 · Cited by 65
Stewart, A. J., Canitrot, Y., Baracchini, E., Dean, N. M., Deeley, R. G., & Cole, S. P. C. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02220-1 · Cited by 66
Self-citationMDR1/P-glycoprotein in haematological neoplasms
Marie, J., Zhou, D.-C., Gurbuxani, S. K., Legrand, O., & Zittoun, R. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00055-x · Cited by 65
P-glycoprotein in Adult Hematologic Malignancies
Marie, J. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30094-7 · Cited by 65
Drug retention, efflux, and resistance in tumor cells
Krishan, A., Fitz, C. M., & Andritsch, I. H. (1997) · Cytometry · doi:10.1002/(sici)1097-0320(19971201)29:4<279::aid-cyto3>3.0.co;2-5 · Cited by 71
PET and SPECT Radiotracers to Assess Function and Expression of ABC Transporters In Vivo
Mairinger, S., Erker, T., Müller, M., & Langer, O. (2011) · Current Drug Metabolism · doi:10.2174/138920011798356980 · Cited by 71
“MRP1 was discovered in 1992 in a multidrug resistant human small cell lung cancer cell line [42].”
BackgroundS-Adenosylmethionine-Dependent Methyltransferase Helps Pichia caribbica Degrade Patulin
Wang, K., Zheng, X., Yang, Q., Zhang, H., Apaliya, M. T., Dhanasekaran, S., Zhang, X., Zhao, L., Li, J., & Jiang, Z. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05144 · Cited by 66
Seo, D., Jung, S. M., Park, J. S., Lee, J., Ha, J., Kim, M., & Park, S. H. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.039 · Cited by 65
Kerr, I. D., Jones, P. M., & George, A. M. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07486.x · Cited by 80
Kim, B., Stephen, S. L., Hanby, A. M., Horgan, K. J., Perry, S., Richardson, J. L., Roundhill, E. A., Valleley, E. M. A., Verghese, E. T., Williams, B. J., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1625-y · Cited by 65
“For example, Multidrug Resistance associated Protein-1 (MRP1; encoded by the gene ABCC1) can export the chemotherapeutics epirubicin and doxorubicin [3, 4], and is overexpressed in a variety of multi-drug resistant cancer cell lines [5, 6].”
BackgroundMahaffey, C. M., Zhang, H., Rinna, A., Holland, W., Mack, P. C., & Forman, H. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.023 · Cited by 64
“Although some cell lines express higher levels of MRPs intrinsically [19,22], chemotherapy, radiation, and other xenobiotic stresses have been shown to increase levels of select MRPs independently [20,21].”
Molecular Pharmacokinetics of Catharanthus (Vinca) Alkaloids
Levêque, D., & Jehl, F. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299430 · Cited by 64
“As for P-gp, MRP (now MRP1 or ABCC1) was first identified as a factor associated with a phenotype of multidrug resistance to certain anticancer agents.(37) In contrast to P-gp, MRP1 is expressed at the basolateral side of enterocytes and kidney cells, thus pumping drugs toward blood.”
BackgroundLiu, C., Lim, Y.-P., & Hu, M. (2012) · Marine Drugs · doi:10.3390/md10010242 · Cited by 67
“MDR1 has been found to promote the efflux of a wide range of structurally and functionally diverse compounds from cells, which decrease their intracellular accumulations [18,19].”
BackgroundLi, W., Sharma, M., & Kaur, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.536136 · Cited by 64
Hepatic drug transporters and nuclear receptors: Regulation by therapeutic agents
Mottino, A. D., & Catania, V. A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.7068 · Cited by 76
Transmembrane Topology of the Sulfonylurea Receptor SUR1
Conti, L. R., Radeke, C. M., Shyng, S., & Vandenberg, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106555200 · Cited by 75
Jäger, W. R., Winter, O., Halper, B., Maier‐Salamon, A., Sartori, M., Gajdzik, L., Hamilton, G., Theyer, G., Graf, J., & Thalhammer, T. (1997) · Hepatology · doi:10.1002/hep.510260613 · Cited by 67
MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte
Ortiz, D. F., Li, S., Iyer, R., Zhang, X., Novikoff, P., & Arias, I. M. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.6.g1493 · Cited by 64
“The rMRP3 gene encodes a protein that exhibits significant amino acid sequence similarity with the glutathione conjugate pumps MRP1 (4) and MRP2 (2, 12, 31) of mammals and YCF1 (37) and Atmrp1 (25) of yeast and plants, respectively.”
BackgroundInfluence of mate drinking, hot beverages and diet on esophageal cancer risk in south america
Castellsagué, X., Mu�oz, N., Stéfani, E. D., Victora, C. G., Castelletto, R. H., & Rol�n, P. A. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001115)88:4<640::aid-ijc19>3.0.co;2-k · Cited by 207
Sharma, R., Singhal, S. S., Cheng, J., Yang, Y., Sharma, A., Zimniak, P., Awasthi, S., & Awasthi, S. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2395 · Cited by 74
Multidrug Resistance in the Laboratory and Clinic
Bellamy, W. T., & Dalton, W. S. (1994) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)60332-7 · Cited by 69
Isolation and Characterization of SUG2
Russell, S. J., Sathyanarayana, U. G., & Johnston, S. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32810 · Cited by 64
van de Ven, R., de Jong, M. C., Reurs, A. W., Schoonderwoerd, A. J. N., Jansen, G., Hooijberg, J. H., Scheffer, G. L., de Gruijl, T. D., & Scheper, R. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5191 · Cited by 63
Wesołowska, O. (2011) · Acta Biochimica Polonica · doi:10.18388/abp.2011_2209 · Cited by 68
“Multidrug resistance-associated protein 1 was first identified in 1992 in doxorubicin-resistant lung cancer cells (Cole et al., 1992).”
BackgroundYuan, J., Wong, I. L. K., Jiang, T., Wang, S. W., Liu, T., Wen, B. J., Chow, L. M. C., & Sheng, B. W. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.05.026 · Cited by 67
Limtrakul, P., Khantamat, O., & Pintha, K. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0848-4 · Cited by 63
“Additional experiments are required to: (1) identify the active compound(s) present in the bitter melon leaf extracts, and (2) explore the effect of bitter melon extract on other drug efflux mechanisms such as the MDR-related proteins [7, 8, 15, 16, 20].”
BackgroundNakamura, T., Oka, M., Aizawa, K., Soda, H., Fukuda, M., Terashi, K., Ikeda, K., Mizuta, Y., Noguchi, Y., Kimura, Y., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0245 · Cited by 68
Lim, S., Hahm, K., Lee, S.-H., & Oh, S. (2010) · Toxicology · doi:10.1016/j.tox.2010.06.010 · Cited by 68
Rémy, E., & Duque, P. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00201 · Cited by 72
“ABCC (MRP) transporters, which have been typically associated with detoxification processes, were first identified in human drug-resistant cancer cells (Cole et al., 1992).”
BackgroundFuture perspectives for the development of P-glycoprotein modulators
Sandor, V. A., Fojo, T., & Bates, S. E. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80039-3 · Cited by 63
Drug resistance in brain tumors
Feun, L. G., Savaraj, N., & Landy, H. J. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01052726 · Cited by 65
Zeng, Y., Wu, X., Fiscella, M., Shimada, O., Humphreys, R. C., Albert, V. R., & Kakehi, Y. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.2.421 · Cited by 67
“Scale bars are 200 μm in panel (1) and (3), and 400 μm in (2).”
BackgroundThe Arabidopsis thaliana ATP‐binding cassette proteins: an emerging superfamily
Davies, T. G. E., & COLEMAN, J. O. D. (2000) · Plant Cell & Environment · doi:10.1046/j.1365-3040.2000.00577.x · Cited by 70
Sharma, V., Prior, J. L., Belinsky, M. G., Kruh, G. D., & Piwnica-Worms, D. R. (2005) · PubMed · Cited by 71
Daoud, R., Michel, J., Gros, P., & Georges, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009782200 · Cited by 63
Cai, L., Struk, B., Adams, M. D., Ji, W., Haaf, T., Kang, H., Dho, S. H., Xu, X., Ringpfeil, F., Nancarrow, J. K., et al. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000079 · Cited by 63
“MRP1 was initially identified based on its overexpression in a doxorubicinresistant human small-cell lung cancer cell line [28].”
BackgroundClinical reversal of drug resistance
Goldstein, L. J. (1995) · Current Problems in Cancer · doi:10.1016/s0147-0272(07)80004-3 · Cited by 67
Choi, J.-H., Lim, H.-Y., Joo, H. J., Kim, H. S., Yi, J. W., Kim, H. C., Cho, Y. K., Kim, M. W., & Lee, K. B. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600305 · Cited by 62
O'Connor, R. A., O’Leary, M., Ballot, J., Collins, C. D., Kinsella, P., Mager, D. E., Arnold, R. D., O’Driscoll, L., Larkin, A., Kennedy, S., et al. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0240-7 · Cited by 66
“One of these, Multi-drug Resistance Protein (MRP-1), has also been extensively characterized [7].”
Effluxing ABC transporters in human corneal epithelium
Vellonen, K., Mannermaa, E., Turner, H. C., Häkli, M., Wolosin, J. M., Tervo, T., Honkakoski, P., & Urtti, A. O. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21878 · Cited by 62
New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition
van der Schoor, L. W. E., Verkade, H. J., Kuipers, F., & Jonker, J. W. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.981152 · Cited by 70
Zhang, W., Fan, Y., Cai, C., Wang, J., Teng, Q., Lei, Z., Zeng, L., Gupta, P., & Chen, Z. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01097 · Cited by 65
Fojo, T., & Coley, H. M. (2007) · Clinical Breast Cancer · doi:10.3816/cbc.2007.n.035 · Cited by 69
Sharma, K. G., Kaur, R., & Bachhawat, A. K. (2003) · Archives of Microbiology · doi:10.1007/s00203-003-0566-z · Cited by 62
Pascolo, L., Petrović, S., Cupelli, F., Bruschi, C. V., Anelli, P. L., Lorusso, V., Visigalli, M., Uggeri, F., & Tiribelli, C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4318 · Cited by 67
Longhurst, T., O’Neill, G. M., Harvie, R. M., & Davey, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.545 · Cited by 66
Intermediate Structural States Involved in MRP1-mediated Drug Transport
Manciu, L., Chang, X.-B., Buyse, F., Hou, Y., Gustot, A., Riordan, J. R., & Ruysschaert, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207963200 · Cited by 77
Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1
Conrad, S., Viertelhaus, A., Orzechowski, A., Hoogstraate, J. A., Gjellan, K., Schrenk, D., & Kauffmann, H.-M. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00354-1 · Cited by 62
Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system
Fulda, S., Łoś, M., Friesen, C., & Debatin, K. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980330)76:1<105::aid-ijc17>3.0.co;2-b · Cited by 182
Aghanejad, A., Babamiri, H., Adibkia, K., Barar, J., & Omidi, Y. (2018) · Bioimpacts · doi:10.15171/bi.2018.14 · Cited by 62
Sulforaphane and erucin increase MRP1 and MRP2 in human carcinoma cell lines
Harris, K. E., & Jeffery, E. H. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.02.014 · Cited by 73
Alqawi, O., Bates, S. E., & Georges, E. (2004) · Biochemical Journal · doi:10.1042/bj20040355 · Cited by 61
“Both P-gp1 (P-glycoprotein) and MRP1 (MDR protein 1) extrude different anticancer drugs in an ATP-dependent manner [ 2 ,3].”
BackgroundAzreq, M.-A. E., Naci, D., & Aoudjit, F. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0132 · Cited by 70
Drug resistance in cancer – searching for mechanisms, markers and therapeutic agents
O'Connor, R. A., CLYNES, M. M., Dowling, P., O’Donovan, N., & O’Driscoll, L. (2007) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.3.6.805 · Cited by 69
“A second cellular pump, MRP-1 (ABCC1), also pumps many of the important cytotoxic chemotherapy drugs [11] .”
BackgroundKim, M. K., Choo, H., & Chong, Y. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500290c · Cited by 63
Aoki, S., Yoshioka, Y., Miyamoto, Y., Higuchi, K., Setiawan, A., Murakami, N., Chen, Z., Sumizawa, T., Akiyama, S., & Kobayashi, M. (1998) · Tetrahedron Letters · doi:10.1016/s0040-4039(98)01336-7 · Cited by 61
Chapter 4 Molecular Mechanisms of Adaptation to Folate Deficiency
Ifergan, I., & Assaraf, Y. G. (2008) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00404-4 · Cited by 75
Aoki, S., Chen, Z., Higasiyama, K., Setiawan, I., Akiyama, S., & Kobayashi, M. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01177.x · Cited by 61
GSH-dependent Photolabeling of Multidrug Resistance Protein MRP1 (ABCC1) by [125I]LY475776
Mao, Q., Qiu, W., Weigl, K. E., Lander, P. A., Tabas, L. B., Shepard, R. L., Dantzig, A. H., Deeley, R. G., & Cole, S. P. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202182200 · Cited by 61
Self-citationHan, J. A., & Park, S. C. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050247 · Cited by 61
“1987), 190-kDa MRP (Cole et al. 1992), GSTp (Mimnaugh et al.”
BackgroundInfluentialRen, X., Furukawa, T., Aoki, S., Nakajima, T., Sumizawa, T., Haraguchi, M., Chen, Z., Kobayashi, M., & Akiyama, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101554200 · Cited by 61
The role of multidrug resistance proteins MRP1, MRP2 and MRP3 in cellular folate homeostasis
Hooijberg, J. H., Peters, G. J., Assaraf, Y. G., Kathmann, I., Priest, D. G., Bunni, M. A., Veerman, A. J. P., Scheffer, G. L., Kaspers, G. J. L., & Jansen, G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01615-5 · Cited by 70
ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum
Hu, X., Plomp, A. S., Wijnholds, J., ten Brink, J. B., van Soest, S., van den Born, L. I., LEYS, A. M., Peek, R., de Jong, P. T. V. M., & Bergen, A. A. B. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200953 · Cited by 65
Localization of a Substrate Specificity Domain in the Multidrug Resistance Protein
Stride, B. D., Cole, S. P. C., & Deeley, R. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22877 · Cited by 65
Self-citationvan de Water, F. M., Masereeuw, R., & Rüssel, F. G. M. (2005) · Drug Metabolism Reviews · doi:10.1080/03602530500205275 · Cited by 71
“MRP1 was originally identified in a lung cancer cell line (Cole et al., 1992), but it is also expressed in many tissues with a detoxification function, like epithelial cells of the kidney, lung, intestine, brain, testis, heart muscle cells, and macrophages and, in lower levels, liver cells…”
BackgroundFukaya, R., Ohta, S., Yamaguchi, M., Fujii, H., Kawakami, Y., Kawase, T., & Toda, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.10.010 · Cited by 63
“ABC transporters are expressed in tumor cells [28] and are associated with drug resistance [29–31], since these transporters export a broad range of cytotoxic drugs [32].”
BackgroundZou, W., MA, X., Wei, H., Chen, B., & CAI, G. (2015) · Oncology Reports · doi:10.3892/or.2015.4320 · Cited by 65
CRISPR/Cas9 and cancer targets: future possibilities and present challenges
White, M. K., & Khalili, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7104 · Cited by 71
Role of organelle pH in tumor cell biology and drug resistance
Simon, S. M. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(98)01276-8 · Cited by 67
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.